Tag Archive
QD Vision Wins AlwaysOn GoingGreen East 50 Award for Second Straight Year (citybizlist Boston)
Developer of Quantum LightTM Nanotechnology-Based Products for Lighting and Displays Named to List H… (more here…) Related items QD Vision Spotlights Advances in Quantum Dot Technology for Solid State Lighting and Displays at Key Industry Events (Business Wire via Yahoo! Finance) NASA R&D Executive Joins Lighting Science Group Corporation; David E. Bartine, Ph.D to Serve as Vice President... »
Gamma Medica-Ideas Licenses Molecular Breast Imaging Technology From Mayo Clinic (Medical News Today)
Gamma Medica-Ideas, Inc. (”GMI”), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O’Connor, PhD. The Company aims to... »
Creative MicroSystems joins international collaboration for medical MEMS (The Valley Reporter)
11/12/2009 By Lisa LoomisWaitsfield-based Creative MicroSystems Corporation, a developer of innovative microscale devices and nanotechnology for renewable energy, biomedical and microelectronics manufacturing applications, has joined an international collaboration with a visit to mainland China for the signing ceremony. (read here…) Related items Apollo Solar Energy, Inc. to Fund a Three-Year, $1.5 Million Sponsorship of the New Jersey... »
NHGRI grants BioNanomatrix $833,490 for commercial development of its NanoAnalyzer system (News-Medical-Net)
BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix’s nanoscale whole genome imaging and … (read on…) Related... »
Xenomics Appoints Bruce A. Huebner as Chief Executive Officer and Board Member (Business Wire via Yahoo! Finance)
NEW YORK—-Xenomics, Inc. a developer of trans-renal molecular diagnostic technologies, announced today the appointment of Bruce A. Huebner, a veteran of the diagnostics industry, as Chief Executive Officer and board director. (more…) Related items MSGI Energy is Formed, Establishing Strategic Partnership with Franklin Energy (Business Wire via Yahoo! Finance) SwissINSO Announces Enhanced Research & Development Capability (Business Wire... »
